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Background: Immune cell adaptor protein ADAP (adhesion and degranulation-promoting adaptor protein)
mediates aspects of T-cell adhesion and proliferation. Despite this, a connection between ADAP and infection by
the HIV-1 (human immunodeficiency virus-1) has not been explored.
Results: In this paper, we show for the first time that ADAP and its binding to SLP-76 (SH2 domain-containing
leukocyte protein of 76 kDa) regulate HIV-1 infection via two distinct mechanisms and co-receptors. siRNA down-
regulation of ADAP, or expression of a mutant that is defective in associating to its binding partner SLP-76 (termed
M12), inhibited the propagation of HIV-1 in T-cell lines and primary human T-cells. In one step, ADAP and its
binding to SLP-76 were needed for the activation of NF-κB and its transcription of the HIV-1 long terminal repeat
(LTR) in cooperation with ligation of co-receptor CD28, but not LFA-1. In a second step, the ADAP-SLP-76 module
cooperated with LFA-1 to regulate conjugate formation between T-cells and dendritic cells or other T-cells as well
as the development of the virological synapse (VS) and viral spread between immune cells.
Conclusions: These findings indicate that ADAP regulates two steps of HIV-1 infection cooperatively with two
distinct receptors, and as such, serves as a new potential target in the blockade of HIV-1 infection.
Keywords: ADAP, HIV-1 transcription, HIV-1 transmission, Integrin, Virological synapseBackground
Infection with the human immunodeficiency virus-1
(HIV-1) causes a severe and selective depletion of CD4+
T lymphocytes in the immune system [1,2]. HIV-1
binds primarily to CD4 together with chemokine
receptors CXCR4 or CCR5. Receptor engagement in-
duces a conformational change in the HIV envelope
glycoprotein (Env), which mediates membrane fusion
and viral penetration. Replication of HIV-1 is mediated
primarily by transcription factors such as NFAT,
AP1 and NF-κB [3,4]. NF-κB regulates long terminal* Correspondence: hongyanwang@sibcb.ac.cn; cer51@cam.ac.uk
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reproduction in any medium, provided the orrepeat (LTR) activation within the HIV-1 genome by
interacting with tandem binding sites in the enhancer
region and mutant IκB alpha inhibits de novo HIV-1 in-
fection in T cells [5-7]. Mutations within internal TATA
sequences or the NF-κB binding sites also impair LTR
activity and viral replication [8].
HIV-1 can disseminate between immune cells either
by cell-free infection or by direct cell-cell spread. Cell-
cell transmission of HIV-1 takes place through mem-
brane nanotubes or virological synapses (VS) that form
following physical contact between infected and unin-
fected cells [9-13]. Electron micrographs have shown
HIV-1 accumulation at the interface between HIV-1
infected and uninfected cells [11,14], while immuno-
fluorescence microscopy and time-lapse imaging have
shown the accumulation of viral proteins at the contact
interface as well as the movement of viruses from one
cell to another [11,15-17]. This mode of dissemination. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cell-free virus [10,16,17], which may facilitate HIV-1
spread within secondary lymphoid tissues [18]. Further,
infected dendritic cells (DCs) and macrophages use the
VS to transfer HIV-1 to T cells [19,20]. Spread via
synapses requires the localization of CD4, CXCR4 or
CCR5 as well as the integrin lymphocyte function-
associate antigen 1 (LFA-1) and intercellular adhesion
molecule-1 (ICAM-1) at the site of cell-cell contact
[10-13,17,20]. The blockade of LFA-1 reduces VS for-
mation [12], and more importantly, DCs isolated from
leukocyte adhesion deficiency (LAD)-I patients show
decreased viral spreading to CD4+ T-cells [21]. Fur-
thermore, LFA-1 and ICAM-1 from host cells can be
incorporated into HIV particles for enhanced infec-
tivity [22,23].
The activation status of T-cells plays an important
role in facilitating viral replication and spread since
HIV-1 replicates inefficiently in quiescent T cells [24].
In this context, immune cell specific adaptor proteins
that mediate T-cell activation and effector functions
have been identified [25,26]. These adaptors lack de-
finable catalytic activities, but instead, possess binding
domains or sites for the formation of multimeric com-
plexes. Of these, Linker of activated T cells (LAT) and
Src homology 2 (SH2) domain-containing leukocyte
protein of 76 kDa (SLP-76) (also named lcp2, lympho-
cyte cytosolic protein 2) are needed for antigen-receptor
induced calcium mobilization [27,28]. SLP-76 binds to
ADAP (adhesion- and degranulation-promoting adaptor
protein, also named as Fyb [fyn binding protein] or SLAP-
130 [SLP-76-associated phosphoprotein of 130 kDa]),
which is needed for up-regulation of LFA-1 adhesion
[29-31]. This pathway is mediated downstream by SKAP1
(Src kinase-associated phosphoprotein 1) that regulates
the complex formation between Rap1 and RapL (regulator
for cell adhesion and polarization enriched in lymphoid
tissues) [26,32-36]. Two tyrosine motifs at Y595DDV and
Y651DDV of ADAP bind to the SH2 domain of SLP-76
upon TCR stimulation. A double point mutation in ADAP
at Y595F and Y651F (termed M12) is defective in SLP-76
binding and shows reduced LFA-1 adhesion and pSMAC
formation [31,34]. Despite this, a potential connection
between ADAP and HIV-1 infection has not been
explored.
In this study, we demonstrate that ADAP and its bin-
ding to SLP-76 regulate two steps of HIV-1 infection by
cooperating differentially with two distinct co-receptors.
Loss of ADAP and the SLP-76/ADAP module mar-
kedly impaired CD28-mediated HIV-1 transcription as
well as LFA-1-dependent formation of virological
synapse for cell-cell viral spread. These findings iden-
tify ADAP and its signaling module as key regulators
of HIV-1 infection.Results
Disruption the SLP-76-ADAP signaling module inhibits
HIV-1 infection
We and others have previously outlined the importance of
the SLP-76-ADAP-SKAP1 pathway in the activation of
LFA-1 [31-36]. A mutant of ADAP lacking tyrosine resi-
dues 595 and 651 (termed M12) is unable to bind to SLP-
76 and impairs LFA-1 activation [31,34]. We assessed
whether wild-type ADAP and the mutant M12 could
regulate HIV-1 infection in Jurkat T-cells (Figure 1A,B).
Jurkat T-cells were stably transduced with retroviral su-
pernatants encoding ADAP-IRES-GFP or M12-IRES-GFP
(termed JK-ADAP/GFP and JK-M12/GFP) or with GFP
alone (JK-GFP). Expression remained stable due to inte-
gration. The transfectants showed the same expression
levels of CD4, CXCR4, CD3, CD28, β1 and β2 integrins as
the control GFP expressing Jurkat cells as measured by
flow cytometry (Figure 1B). We next infected these cells
with a single-cycle HIV-1 virus carrying a luciferase
reporter (equivalent to 5 ng p24Gag). The mRNA levels of
HIV-1 gag were measured at 72 hours post-infection by
quantitative RT-PCR (qRT-PCR) with specific primers for
HIV-1 gag. JK-ADAP/GFP cells showed 3-4-fold higher
levels of HIV-1 gag mRNA when compared to JK-GFP
cells. By contrast, JK-M12/GFP cells failed to support the
increase of HIV-1 gag mRNA beyond that observed in the
JK-GFP cells (Figure 1A). The level of transfected M12
was similar to ADAP as seen by western blotting
(Figure 1A, upper right inset). We confirmed that after
HIV-1 infection, overexpression of ADAP/GFP or M12/
GFP had no effects on CD4 or CXCR4 expression in
Jurkat cells (Additional file 1: Figure S1A).
We next stably overexpressed GFP, ADAP or M12 into
human C8166 T cells (C8166-GFP, C8166-ADAP and
C8166-M12) (Additional file 1: Figure S1B). These cells
were infected with low dose or high dose of HIV-1
(equivalent to 1.5 or 15 ng p24Gag, respectively). Superna-
tants were collected and quantified by ELISA for levels of
of HIV-1 p24Gag at various times post-infection. We found
that at both doses of input virus, C8166-M12 cells were
impaired in their support of HIV-1 replication relative to
cells expressing wild-type ADAP. When we used low dose
of virus to infect cells, C8166-ADAP cells and the control
cells supported productive infection, whereas C8166-M12
cells failed to produce the detectable levels of p24Gag
(Additional file 1: Figure S1B, right panel). Over 95% of
C8166 T cells overexpressed GFP, or ADAP/GFP or M12/
GFP (Additional file 1: Figure S1B, left and middle panels),
which had no effect on the expression of surface receptors
(Additional file 1: Figure S1C) and showed similar growth
rates (Additional file 1: Figure S1D). We further examined
whether HIV-1 infection of human primary CD4+ T cells
was dependent on ADAP (Figure 1C,D). ADAP expression
was reduced using specific siRNAs. qRT-PCR showed a
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Figure 1 (See legend on next page.)
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Figure 1 Disruption the SLP-76-ADAP signaling module inhibits HIV-1 infection in T-cells. (A) Jurkat T cells were stably transfected with
GFP, ADAP/GFP or M12/GFP and infected with single-cycle luciferase reporter HIV-1 (equivalent to 5 ng p24Gag/106 cells). The HIV-1 gag mRNA
levels were determined by qRT-PCR 72 hrs post infection (P = 0.032, left and P = 0.005, right). The ADAP/M12 expression levels were examined by
immunoblotting. (B) Overexpression of ADAP/GFP or M12/GFP in Jurkat cells did not alter the surface expression levels of CD4, CXCR4, CD3,
CD28, β1 or β2 integrins as determined by flow cytometry. (C) Human primary CD4+ T cells were transfected with the scramble siRNA or siRNA
targeting ADAP, and the knockdown efficiency was confirmed by immunoblotting (48 hrs post-transfection) or by qRT-PCR at different time
points during HIV-1 infection. (D) Human primary CD4+ T cells were transfected with siRNAs for 24 hrs, then infected with single-cycle luciferase
reporter HIV-1. The HIV-1 gag mRNA levels were determined by qRT-PCR 72 hrs post infection (left panel, P = 0.0192). Alternatively, the amount of
HIV-1 was measured according to the luciferase readings (right panel, P = 0.0032) (* represents p = <0.05, ** represents p = <0.01).
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period of 96 hours post-transfection (Figure 1C). Similarly,
western blotting of cells at 48 hours confirmed the signi-
ficantly reduced ADAP expression after transfection with
siRNA-ADAP (Figure 1C, right inset). siRNA transfected
human CD4+ T cells were then infected with the single-
cycle HIV-1 virus containing luciferase reporter [12].
siRNA for ADAP reduced HIV-1 gag mRNA levels by
30% when assessed at 72 hours post-infection (Figure 1D,
left panel). A measurement of luciferase activity confirmed
that siRNA for ADAP resulted in a significant reduction
of HIV-1 infection (Figure 1D, right panel). The surface
expression of CD3, CD4, CD28, CXCR4, β1/β2 integrins
and ICAM-1 in human CD4+ T cells was not affected by
knockdown of ADAP (Additional file 1: Figure S1E).
Collectively, these data indicate that ADAP is needed for
the optimal HIV-1 infection of T-cell lines and primary
human T-cells.
ADAP and SLP-76 regulates HIV-1 LTR transcription in a
CD28- and NF-κB-dependent manner
To uncover the molecular basis of ADAP involvement
in HIV-1 infection, we firstly examined its potential ef-
fects on the induction of HIV-1 LTR transcription. Wild
type, SLP-76-deficient Jurkat T-cells (termed J14) or
ADAP-deficient Jurkat T-cells (termed JDAP) [37] were
transfected with a pLTR-gag3-flag-luc reporter plasmid
followed by stimulation via anti-CD3/CD28 ligation for
6 hours. The pLTR-gag3-flag-luc plasmid contains the
HIV-1 5’ LTR promoter region with two NF-κB binding
sites and a firefly luciferase open reading frame [38].
HIV-1 transcription was then assessed by a measure of
luciferase activity (Figure 2A). Anti-CD3/CD28 stimula-
tion induced a two-fold increase in HIV-1 transcription
in wild type Jurkat cells, an effect that was not seen in
J14 cells (Figure 2A, upper left panel). Re-expression of
SLP-76 into J14 cells restored and enhanced HIV-1 tran-
scription (blue bars). Similarly, anti-CD3/CD28 induced
HIV-1 transcription was markedly impaired in ADAP-
deficient JDAP cells (Figure 2A, upper right panel). Fur-
thermore, the overexpression of SLP-76 in JDAP cells
did not bypass or compensate for the ADAP deficiency
(Figure 2A, lower panel). Anti-CD3/CD28 increased
NF-κB binding by over 3-fold in wild type Jurkat cells asmeasured by an electrophoretic mobility shift assay
(EMSA) (the integrated OD values from Gel-Pro image
analysis software: 136 to 450), but not in JDAP cells
(Figure 2B, left panel). In agreement with this, a dif-
ference in the degradation of IκB alpha was observed
between wild type and JDAP cells (Figure 2B, right
panel). IκB alpha is an inhibitor of NF-κB which is de-
graded in response to TCR/CD28 ligation [39]. Anti-
CD3/CD28 induced a degradation of IκB alpha in Jurkat
cells over a period of 90-120 min, an effect that was not
observed in JDAP cells. Instead, JDAP cells sustained
IκB alpha expression over the time course. These obser-
vations indicate that ADAP expression is needed for
anti-CD3/CD28 induced NF-κB activation.
We also assessed the effect of ADAP binding to SLP-76
to regulate HIV-1 transcription by using cells transfected
with wild type ADAP or the mutant M12 (Figure 2C).
ADAP expression increased anti-CD3/CD28 induced
transcription of the HIV-1 LTR by 2.5 fold, while this was
impaired with M12 (i.e. 30-40 percent less than observed
for ADAP, Figure 2C, left panel). ADAP overexpression
also increased HIV-1 transcription in response to anti-
CD3 and CD80-Fc, the natural ligand for CD28 (Figure 2C,
right panel). Further, an EMSA assay showed that ADAP
increased NF-κB activation (OD values from 11 to 68),
and this increase was blocked by M12 (OD values from 16
to 24) (Figure 2C, middle panel). As a control, ADAP
could not further enhance the activity of a HIV-luciferase
reporter lacking NF-κB binding sites (Additional file 2:
Figure S2A). Significantly, the same inhibitory effect of
M12 was noted in primary human T-cells that had been
co-transfected with pLTR-gag3-flag-luc and ligated with
anti-CD3/CD28. ADAP expression increased HIV tran-
scription by 2.5-3 fold, whereas M12 had no effect
(Figure 2D). These data indicate that ADAP and its bin-
ding to SLP-76 cooperate with CD28 co-ligation to regu-
late LTR activity in Jurkat and human primary T-cells.
Stimulation of T-cells from CD28 deficient Jurkat cells
further showed a dependency of the NF-κB-driven HIV-
1 transcriptional response on CD28 (Figure 2E, left
panel). Anti-LFA-1 antibody (i.e. anti-CD18) ligation had
no ability to activate HIV-1 transcription alone, or in
conjunction with CD3/CD28 ligation or ADAP/GFP ex-
pression (right panel). These data indicate that CD28,
Figure 2 ADAP and SLP-76 regulates HIV-1 LTR transcription in a CD28- and NF-κB-dependent manner. (A) The pLTR-gag3-flag-luc
luciferase reporter plasmid was transfected together with GFP or SLP-76-GFP into Jurkat, SLP-76 deficient J14 cells (upper left panels, P = 0.0112 left; P =
0.002 right) or ADAP deficient JDAP cells (lower left panel, P = 0.0145). Alternatively, this reporter plasmid was transfected into Jurkat or JDAP cells (upper
right panel, P = 0.0203). These cells were stimulated with or without anti-CD3/CD28 to measure HIV-1 LTR transcription. (B) EMSA assay and immunoblotting
with anti-IκBα showed that the loss of ADAP markedly decreased anti-CD3/CD28-induced NF-κB activation. The absolute integrated OD values of each band
were analyzed by Gel-Pro (left panel). (C) Plasmids expressing GFP or ADAP/GFP or M12/GFP were transfected together with the luciferase reporter plasmid
into Jurkat cells to assess the luciferase activity after anti-CD3/CD28 (left panel, P < 0.0001) or anti-CD3/CD80-Fc (right panel, P < 0.05) stimulation. The NF-κB
activation was examined by an EMSA assay (middle panel). (D) Human primary PBLs were transfected with GFP or ADAP/GFP or M12/GFP together with the
luciferase report plasmid to measure HIV-1 LTR transcription (P < 0.01). (E) CD28 deficient Jurkat cells (upper panel) or wild type Jurkat cells (lower panel)
were stimulated by anti-CD3/CD28 with or without anti-LFA-1 blocking to check HIV-1 transcription (P > 0.05). (F) Jurkat cells expressing GFP or ADAP/GFP
were treated with indicated specific inhibitors, followed by a measurement of the HIV-1 mRNA levels. (G) Human primary PBLs were transfected with GFP or
ADAP/GFP, stimulated by anti-CD3/CD28 with or without the src kinase inhibitor PP2 to measure HIV-1 LTR transcription (NS/not significant; P = 0.1465).
Three independent experiments were performed and the representative data are shown with error bars (*p = <0.05, **p = <0.01).
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the activation of HIV-1 transcription.
We next determined whether ADAP activation of the
HIV-1 LTR intersects with other signaling events. Specific
inhibitors of src kinases, phosphotidylinositol 3 kinase
(PI 3 K) and phospholipase C (PLC) were used in con-
junction with anti-CD3/CD28 stimulation. We measured
the HIV-1 gag mRNA levels by qRT-PCR (Figure 2F) or
HIV 5’ LTR transcription activity (Additional file 2:
Figure S2B). Src kinase inhibitor PP2 and PLC inhibitor
U73122 significantly decreased anti-CD3/CD28 induced
HIV-1 transcription in Jurkat cells, and reduced the
increase observed in ADAP/GFP expressing cells. The
inhibitory effect of PP2 on HIV-1 transcription was also
observed in primary human T-cells (Figure 2G), sho-
wing that ADAP expression increased anti-CD3/CD28
induced transcription by 2.5-fold, which was blocked by
PP2 treatment. The PI 3 K inhibitor LY294002 however
did not affect transcription (Additional file 2: Figure S2B).
We previously showed that this concentration of
LY294002 effectively inhibited PI 3 K in Jurkat cells by
examining protein kinase B (AKT/PKB) phospho-
rylation [40]. These data indicate that src kinases and
PLC are needed for ADAP enhancement of anti-
CD3/CD28 induced HIV-1 transcription.
LFA-1 dependency in ADAP-induced HIV-1 infection
The striking effects of M12 on HIV-1 replication suggested
that additional mechanisms might also be operating. Of
particular interest was the involvement of ADAP on the ac-
tivation of LFA-1 for adhesion [31,34]. To assess the de-
pendency on ADAP-induced LFA-1 adhesion during HIV-1
infection, single-cycle HIV-1 containing a luciferase re-
porter was incubated with C8166 cells expressing GFP con-
trol, ADAP/GFP or M12/GFP. These cells were either left
untreated, or incubated with virus in the absence or pres-
ence of soluble ICAM-1-Fc or anti-LFA-1 to block LFA-1
-mediated adhesion (Figure 3A). HIV-1 gag mRNA levels
were assessed using qRT-PCR with specific primers for
HIV-1 gag (Figure 3A, left panel). Gag mRNA levels were
reduced in the control/GFP (i.e. from 0.7 to 0.3, p ≤ 0.05)
and ADAP/GFP cells (i.e. from 1.4 to 0.3, p ≤ 0.01) in the
presence of soluble ICAM-1-Fc treatment. In contrast, the
already impaired levels of HIV-1 gag mRNA production in
M12/GFP cells (i.e. 1.4 vs. 0.35 when compared to ADAP/
GFP cells, p ≤ 0.01) was not further reduced by the presence
of ICAM-1-Fc. Similar to the blocking effect by soluble
ICAM-1-Fc, anti-LFA-1 antibody also impaired HIV-1 gag
mRNA production (Figure 3A, left panel). We also mea-
sured the luciferase reading from the single-cycle luciferase
reporter HIV-1-infected cells, where soluble ICAM-1-Fc or
anti-LFA-1 treatment reduced luciferase readings in the
controls and ADAP/GFP expressing C8166 cells (Figure 3A,
right panel). Consistently, the decreased luciferase readingin M12/GFP cells was not further reduced by soluble
ICAM-1-Fc or anti-LFA-1 treatment (Figure 3A, right
panel). As a control, flow cytometry confirmed that ADAP
and M12 did not alter LFA-1 expression (Figure 3B). In
addition, using higher levels of HIV-1 particles (5 ng
p24Gag), ADAP expression enhanced the luciferase values
relative to the GFP transfected control, while M12 markedly
decreased the amount of viruses). Consistent results were
also observed when these cells were incubated with lower
quantities of virus (1 ng p24Gag) (Figure 3C). These data in-
dicate that the SLP-76-ADAP module regulates HIV-1 in-
fection in an LFA-1-dependent manner.
SLP-76-ADAP regulates the VS formation between T-cells
and DCs
The blockade of ADAP-induced HIV-1 infection with sol-
uble ICAM-1-Fc suggested that ADAP might contribute to
integrin-mediated viral transmission via affecting the for-
mation of VS and cell-cell conjugation. LFA-1 adhesion is
known to modulate T-cell conjugation with dendritic cells
(DCs) or T-cells, even in an antigen independent manner;
and T-cells or DCs expressing HIV-1 can spread the virus
by forming conjugates with non-infected T-cells [11-16].
We therefore investigated whether ADAP and SLP-76
could regulate conjugation between DCs and non-infected
T cells. For this, Jurkat, JDAP and J14 cells were incubated
for 1 hour with mature human DCs that were pre-pulsed
with HIV-1-gag-GFP, followed by the scoring of closely op-
posed pairs of HIV1-gag-GFP expressing DCs and T-cells.
Examples of HIV-1-gag-GFP-pulsed DCs and anti-ADAP
stained T-cells are shown (Figure 4A). HIV-1-gag-GFP in
DCs and ADAP in T-cells localized at the contact region
between cells. Our previous reports have demonstrated that
M12 disrupted its binding with SLP-76, and reduced LFA-1
-mediated conjugates formation between antigen presenting
cells and T cells [31,34]. We asked whether the mutant M12
could impair DC-T conjugation and virological synapse for-
mation. Jurkat T cells stably overexpressing GFP, ADAP/
GFP or M12/GFP were incubated with mature human DCs
that were pre-pulsed with HIV-1-gag-GFP (Figure 4B).
ADAP expression enhanced conjugate formation between
DC and T cells (64% vs. 47% compared to vector controls,
p ≤ 0.05). By contrast, M12 expression significantly de-
creased conjugation (64% vs. 38%, p ≤ 0.01). Notably, ADAP
also enhanced the formation of VS as defined by the pres-
ence of HIV-1 at the interface (65% vs. 49%, p ≤ 0.05), while
M12 expression reduced VS formation to 39% (p ≤ 0.01). In
the case of vector and ADAP transfected cells, LFA-1 and
HIV-1 co-localized at the interface (Figure 4B, right panels).
Further, similar results were seen in comparing conju-
gation of Jurkat relative to JDAP cells (Figure 4C). JDAP
cells formed significantly fewer conjugates than Jurkat
cells (i.e. from 37% to 22%; p ≤ 0.01). J14 also blocked
the conjugate formation with infected DCs to a similar
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Figure 3 LFA-1 dependency in ADAP-induced HIV-1 infection. (A) Single-cycle luciferase reporter HIV-1 was incubated for 2 hrs at 37 degree with
C8166 cells that over-expressed GFP control or ADAP/GFP or M12/GFP, in the absence or presence of soluble ICAM-1-Fc or anti-CD18 treatment. After
washing, these C8166 cells were further cultured for 72 hrs with or without soluble ICAM-1-Fc or anti-CD18. The amount of HIV-1 was measured by qRT-
PCR using primers specific for the HIV-1 gag mRNA relative to an actin housekeeping gene (left panel) or was determined by luciferase assay (right panel).
(B) Overexpression of ADAP or M12 in C8166 cells did not alter the surface expression levels of LFA-1. (C) Low (1 ng p24Gag) or high (5 ng p24Gag)
amount of single-cycle luciferase reporter HIV-1 viruses were used to infect C8166 cells over-expressing GFP control or ADAP/GFP or M12/GFP. The
luciferase readings were collected from triplicate samples with error bars (* represent p = <0.05, ** represents p = <0.01, *** represents p = <0.001).
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formed conjugates, HIV-1-gag-GFP localization was re-
duced at the contact region when DCs contacted with
JDAP cells or J14 cells (Figure 4C). While 46% of wild-
type T-cells showed HIV-1-gag-GFP localization at the VS,
only 15% of the JDAP or J14 cells showed this feature
(Figure 4C). As noted, deficiency of ADAP in JDAP cells
(Figure 1B) or deficiency of SLP-76 in J14 cells (Additional
file 3: Figure S3A) did not affect LFA-1 expression. Next,
we confirmed that knockdown of ADAP in human pri-
mary CD4+ T cells decreased both conjugate formation
(from 41% to 27%, p ≤ 0.05) and VS formation (from 53%
to 31%, p ≤ 0.01) (Figure 4D). Taken together, these data
indicate that the loss of ADAP or SLP-76 or disruption of
the binding between SLP-76 and ADAP impairs conjuga-
tion and VS formation between T-cells and DCs.
The SLP-76-ADAP module regulates viral transfer
between T-cells
To assess viral-infected T-cells conjugation with non-
infected T-cells, ADAP or M12 expressing target T cells(i.e. GFP positive) were incubated with HIV+ donor T
cells infected with a CXCR4-tropic HIV-1 virus isolate
(pNL43). Conjugates were allowed to form for 1 hour
with a human non-inhibitory anti-HIV Env monoclonal
antibody to stain surface Env (blue), while HIV-1 Gag
p17 and p24 were intracellular stained (red) (Figure 5A).
Conjugates were scored as apposed pairs consisting of
one GFP+ target cell and a HIV Gag+ donor cell. Exam-
ples of a conjugate with the GFP labeled T-cell (panel a),
Env staining (panel b), anti-Gag staining (panel c) and
the merged image (panel d) are shown (Figure 5A, left
panels). While ADAP supported the formation of con-
jugates amongst 65% of the cells, M12 reduced this to
38% (p = 0.02) (Figure 5A, middle panel). Amongst the
remaining cells that formed conjugates, a similar num-
ber of ADAP or M12 expressing cells formed a detec-
table VS region (Figure 5A, right panel). However, a
significant difference was noted in the size of the VS
interface formed between viral-infected T cells with
ADAP or M12 expressing target cells (Figure 5B,
p = <0.001). While ADAP expressing cells showed an
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Figure 4 SLP-76-ADAP regulates the VS formation between T-cells and HIV-1-pulsed DCs. Jurkat, JDAP or J14 cells were incubated for
30 min with mature human DCs that were pre-pulsed with HIV1-gag-GFP VLPs. Conjugate formation and the presence of HIV1-gag-GFP at the VS
interface was assessed. (A) Example of a conjugate shows that anti-ADAP staining in T-cells and HIV1-gag-GFP VLPs in DCs were peaked at the
interface between DC and T cell. (B) Jurkat cells stably overexpressing GFP, ADAP/GFP or M12/GFP were incubated for 30 min with HIV1-gag-GFP-
pulsed human DCs. Represent examples are shown in right panels. Histograms show the percent of conjugate formation (left panel; P = 0.0198 left,
P = 0.0068 right) and colocalization of HIV1-gag-GFP and LFA-1 at the VS (right panel; P = 0.0107 left, P = 0.0022 right). (C) Deficiency of ADAP (JDAP) or
deficiency of SLP-76 (J14) impaired HIV1-gag-GFP and LFA-1 localization at the interface between Jurkat cells and DCs. Histograms show the percent
of conjugate formation (upper panel, P = 0.0011 left, P = 0.043 right) or colocalization of HIV1-gag-GFP with LFA-1 at the VS (lower panel, P = 0.0006).
(D) Human primary CD4+ T cells were transfected with the scramble siRNA or siRNA ADAP for 48 Hrs, which were then incubated for 30 min with
mature human DCs pre-pulsed with HIV1-gag-GFP VLPs. The conjugate formation (P = 0.0241) and HIV1-gag-GFP at the VS interface (P = 0.0018) were
analyzed and showed in histograms. Typical examples were shown in right panel. Typical examples are shown in right panel (* represents p = <0.05,
** represents p = <0.01, *** represents p = <0.001).
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http://www.retrovirology.com/content/10/1/101average contact site of 6.4 units, M12 conjugates re-
duced this to 4.1 units (Figure 5B). In agreement with
this, the loss of ADAP dramatically inhibited anti-CD3
and ICAM-1- induced cell spreading (Additional file 3:
Figure S3B).To assess the effect of ADAP and M12 on HIV-1
transmission between T cells, we next quantified cell-cell
spread using a well-defined qRT-PCR assay in which the
copy number of HIV-1 pol gene was measured and enu-
merated relative to an albumin housekeeping gene
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Figure 5 The SLP-76-ADAP module regulates viral transfer between T-cells. (A) ADAP/GFP and M12/GFP expressing target cells were mixed
with HIV infected donor T cells. Conjugates were defined as closely apposed pairs consisting of one GFP + target cell and a HIV Gag + donor cell.
Represent examples show interfacial localization of Gag (red) and Env (blue) proteins between GFP + target cell and a HIV-donor Jurkat cell. Over
200 conjugates from each sample were counted. Data are from three independent experiments and error bars show the SEM (p < 0.05).
(B) Representative images of ADAP/GFP cell (a,b) and M12/GFP (c,d) cell in contact with a Gag + cell (left panels). Analysis of cell-cell contact
surface. Reduced interface size amongst cells that formed conjugates with M12 (p < 0.0001). Bars are represented as means ± SD (n = 32)
(right panel). (C) M12 reduces HIV-1 spread amongst T-cells. Quantitative RT-PCR was performed using primers specific for the HIV pol gene and
an albumin house-keeping gene. The ratio of HIV pol DNA to albumin was determined as the HIV DNA copy number. The fold increase was
calculated relative to the amount of DNA at the time point 0 h. Data are from three independent experiments and error bars show the SEM.
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relative to the number of DNA copies at time point
0 hour to account for the presence of integrated proviral
DNA within the infected donor cell population. HIV pol
copy number corresponds to de novo HIV-1 DNA syn-
thesis. An increase above 1 reflects reverse transcription
as a result of cell-to-cell spread and new infection of the
target cells. While the presence of ADAP sustained cell-
to-cell spread, M12 expression induced a significant re-
duction in viral transfer between cells (i.e. 3.5 vs. 2.2).
Overall, these data indicate that M12 effectively reduces
the number of T-T cell conjugates and the size of the
VS, leading to reduced HIV-1 viral transmission.
Discussion
Although ADAP acts as an important mediator of T-cell
signaling and function [29-32,34,37,41], its role in HIV-1
infection of T-cells had yet to be explored. In this study,
we showed that ADAP was a potent regulator of twocentral events needed for HIV-1 infection, namely, the
HIV-1 LTR transcription and viral transfer at the sy-
napses of T-T or DC-T conjugates. Further, the two
functions were regulated by two different co-receptors,
CD28 in the case of HIV-1 transcription, and LFA-1 in
the case of cell-cell transmission. Expression of M12 or
the down-regulation of ADAP by siRNA effectively
suppressed the propagation of HIV-1. Our findings
therefore identify ADAP and the SLP-76/ADAP signal-
ing module as new potential targets for the repression of
HIV-1 infection.
Our studies have demonstrated that ADAP regulates
two distinct events during HIV-1 infection of T-cells.
While NF-κB drives the replication of the long terminal
repeat (LTR) [5], the identity of the full range of up-
stream regulators of NF-κB-LTR is unknown. A variety
of pro-inflammatory stimuli such as TNF-α and IL-1 as
well as viral proteins and stress inducers are potent
activators [42]. In T-cells, protein kinase Cθ (PKCθ) and
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[43-45]. Phorbol ester activation of PKCs can reactivate
HIV-1 in cell lines and importantly, in primary quiescent
T cells [46,47]. More recently, members of the LAT
signalosome including ADAP have been found to be
needed for optimal NF-κB activation [41,48]. However,
given the different members of the NF-κB family that
can be affected by upstream mediators, it has been
unclear whether ADAP is needed for HIV-1 LTR tran-
scription. Our findings showed a significant loss of anti-
CD3/CD28 induced HIV-1 transcripts in JDAP cells,
indicating that ADAP is needed for LTR activation. This
in turn was reflected by a lack of detectable IκBα
degradation in ADAP deficient JDAP cells. This regula-
tory event was linked further upstream to SLP-76, since
a loss of binding to SLP-76 by the M12 mutant impaired
LTR activity in Jurkat and primary human T-cells. It is
important to note that overexpression of SLP-76 into
JDAP cells did not rescue the defective HIV-1 LTR tran-
scription. This observation suggests that ADAP is the
downstream effector of SLP-76 to regulate HIV-1 tran-
scription. Overexpression of SLP-76 increased HIV-1
LTR transcription in WT and SLP-76 deficient J14 Jurkat
cells. This effect of SLP-76 on transcription differs from
a previous study [49]. The basis of this difference is
unclear; however, different results might be caused by
different methods used in these studies. Those authors
examined the amount of full-length or sliced HIV tran-
scripts by qRT-PCR after J14 or wild type cells were
infected with HIV-1 IIIB virus. We used anti-CD3/CD28
to activate J14 or wild type cells and the readout was
based on the HIV LTR luciferase reporter assay. The de-
pendency of NF-κB activation on CD28 expression and
its engagement in our studies might explain the dif-
ferences in results. In either case, our findings are con-
sistent with a scenario of SLP-76 upstream regulation of
ADAP that in turn is the effector in the regulation of
NF-κB transcription.
Further, we observed that the inhibition of Src kinase
and PLCγ1 activity blocked ADAP potentiation of HIV-1
LTR transcription in response to anti-CD3/CD28 stimu-
lation. This finding is consistent with the observation
that p59fyn can bind and phosphorylate ADAP, while
p56lck is potentially involved in NF-κB activation [50].
Consistent with other reports, PLCγ1 activity is required
in guanine nucleotide exchange factor Vav-1 induced
activation of NF-κB [51]. Overall, our data indicate for
the first time that ADAP and SLP-76 are needed for
anti-CD3/CD28-induced NF-κB binding to the HIV-1
LTR and optimal HIV-1 transcription.
Our second major observation was that ADAP regu-
lated HIV-1 transmission between DC-T or T-T cells.
Evidence has accumulated over the years showing effi-
cient viral spread by direct cell-cell contact [52]. In ourstudy, while the blocking of LFA-1 had no effect on the
NF-κB-driven HIV-1 LTR transcription, it nevertheless
effectively impaired HIV-1 infection. This observation
underscored the distinct nature of the two steps affected
by ADAP. JDAP cells and human primary CD4+ T cells
with reduced ADAP expression by siRNA formed mar-
kedly reduced numbers of T-DC conjugates and showed
decreased HIV-1-GFP VLP localization at the VS inter-
face. We observed that the M12 mutant also inhibited
T-T conjugate formation, while the remaining conjugates
showed a reduced size of the interface at VS. Both
events would be expected to interfere with the optimal
viral spread between cells. Finally, in agreement, the
de novo HIV DNA synthesis as measured by levels of
HIV pol in T-cell cultures confirmed a significant reduc-
tion in viral spread.
The identity of other signaling mediators other than
src kinases and phospholipase C that cooperate with
ADAP to regulate the VS formation and cell-to-cell viral
spread remains to be determined. ITK and ZAP-70 are
needed for viral cell-cell transmission [53,54], whereas
ADAP has additional binding sites for vasodilator-
stimulated phosphoprotein (VASP), a regulator of actin
branching [55]. LFA-1 ligation can re-model actin in
T-cells [31,56,57] and T cells require actin polyme-
rization for HIV-1polarization at the cell-cell contact
area. This in turn is needed for the proper formation of
the VS between T-cells, as well as the efficient entry of
HIV-1 into activated CD4+ T cells [57]. In agreement,
we observed reduced cell spreading in JDAP cells, as
well as a reduced interface between HIV-1 infected T
cells and non-infected M12 cells. The inside-out path-
way is linked ADAP with the downstream SKAP-1,
which is needed for the RapL-Rap1 complex formation
and binding of this complex to the cytoplasmic tail of
LFA-1 [32,33,35,36,58]. In this context, LFA-1 also
determines the preferential infection of memory CD4+
T cells by HIV-1 [59]. Together, ADAP and the SLP-
76-ADAP complex represent exciting novel targets for
reducing two steps of HIV-1 infection.
Conclusion
This study is the first reported demonstration that ADAP
and the SLP-76/ADAP signaling module play central roles
in two distinct phases of HIV-1 infection. Firstly, ADAP
cooperated with the co-receptor CD28 and TCR to
enhance HIV-1 LTR transcription via the regulation of
NF-κB. This regulatory event was dependent on expres-
sion of co-receptor CD28, as well as the activity of src
kinases and phospholipase C. Phosphoinositol 3-kinase
(PI 3 K) and LFA-1 were not needed for ADAP regulation
of HIV-1 LTR transcription. By contrast, SLP-76/ADAP
regulation of viral cell-cell spread was reflected by a
reduction in LFA-1-dependent DC-T or T-T cell
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M12, as well as well as impaired formation of the VS be-
tween cells. Overall, our evidence shows that ADAP and
its binding to SLP-76 regulates propagation of HIV-1 by
two distinct coreceptors, and identifies the immune
adaptor ADAP as a new possible target to control HIV-1
infection.
Methods
Cells
ADAP or M12 was subcloned into the retroviral vector
pMXF5 containing IRES-GFP, and these plasmids were
transfected in 293 T cells to prepare retroviral supernatants.
Human C8166 and Jurkat T cells were transduced with
these retroviral supernatants, and GFP+ cells were sorted
by flow cytometry, which could stably express GFP vector
or ADAP/GFP or M12/GFP. C8166 cells, Jurkat T cells, J14
(SLP-76 deficient) cells and JDAP (ADAP deficient) cells (a
kind gift from Dr. Y. Huang, National Institutes of Health,
Intramural Research Program/Department of Health
and Human Services, Baltimore, Maryland, USA) were
cultured in RPMI 1640 medium supplemented with
10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin,
100 μg/mL streptomycin at 37°C and 5% CO2. CD14
+
monocytes were purified from human PBMCs (human
peripheral blood mononuclear cells) using anti-CD14
antibodies-coated magnetic beads (BD Biosciences) and
cultured with 50 ng/ml of granulocyte-macrophage colony
stimulating factor (GM-CSF) (R&D) and IL-4 (R&D) for
6 days to generate immature DCs. Immature DCs were
stimulated with LPS (10 ng/ml) for 48 h to generate ma-
ture DCs. Primary CD4+ T cells were purified from human
PBMCs using anti-CD4 antibodies-coated magnetic beads
(BD Biosciences) and activated with 5 μg/mL of
phytohemagglutinin-P (PHA-P) (Sigma-Aldrich) for 72 h
in the presence of 20 IU/mL of recombinant IL-2 (R&D).
CA-p24 ELISA assay
To measure HIV-1 p24Gag levels in the culture medium,
culture supernatant was firstly heat inactivated at 56°C
for 30 min in the presence of 0.05% Empigen-BB
(Calbiochem, La Jolla, USA) and the CA-p24 concentra-
tion was determined by ELISA with D7320 (Biochrom,
Berlin, Germany) as the capture antibody and alkaline
phosphatase-conjugated anti-p24 monoclonal antibody
(EH12-AP) as the detection antibody using a lumiphos
plus system (Lumigen, Michigan, USA) in a LUMIstar
Galaxy luminescence reader (BMG labtechnologies,
Offenburg, Germany).
HIV LTR driven transcription by luciferase assay
The pLTR-gag3-flag-luc plasmid contains the HIV-1 5’
LTR promoter region, the complete leader RNA, the N-
terminal three Gag amino acids followed by the Flagpeptide (amino acids DYKDDDDKD) and the firefly
luciferase protein. The pLTR-gag3-flag-luc plasmid was
transfected in Jurkat cells together with plasmids
expressing ADAP/GFP, M12/GFP or GFP alone. Trans-
fected cells were then seeded on to anti-CD3 and anti-
CD28 or purified B7.1-Fc coated plate for 6 hrs. Cells
were then harvested, lysed and measured for luciferase
activity according to the protocol provided by Promega
kits. Alternatively, transfected cells were treated with
src kinase inhibitor PP2, PI3K inhibitor LY294002,
PLCγ inhibitor U73122 or anti-LFA1 antibody (i.e. anti-
CD18) over the incubation period.Knockdown of ADAP expression by siRNA
Specific siRNAs targeting human ADAP (5’-CCUGGU
GAAUCUCUAGAAGTT-3’) or scrambled control siRNAs
were transfected into human primary CD4+ cells using
Lipofectamine 2000 (Invitrogen) as directed by the
manufacturer. The levels of ADAP expression were
examined by Western blotting at 48 h after transfection
or by qRT-PCR at various time points.Immunoprecipitation, immunoblotting and EMSA assay
To check the activity of NF-κB, Jurkat and JDAP cells or
C8166 cells over-expressing ADAP/GFP, M12/GFP and
GFP control were stimulated with anti-CD3 (1 μg/ml)
and anti-CD28 (2 μg/ml) antibodies for 30 min or in-
dicated time. Nuclear extracts were prepared and incu-
bated with biotin labelled NF-κB probes. Activated
NF-κB formed a complex with NF-κB probes that could
be detected according to Panomics’s protocol. Alterna-
tively, cell lysates were prepared for immunoblotting
with IκBα and actin to detect the degradation of IκBα.HIV-1 stocks and viral-like particles (VLPs)
CXCR4-tropic HIV-1 virus (pNL4.3) was generated by
transfecting 293T cells as described below and infec-
tivity determined by luciferase assay on HeLa tzmbl
cells. HIV-1 viral stocks produced in C33A cells (24
wells plate) were produced by transfection of 1 μg of
pLAI-R37. Pseudotyped single-cycle, luciferase reporter
HIV stocks, HIV-Luc/NL4-3, were generated by calcium
phosphate-mediated cotransfections of HEK293T cells
with pLAI-Δenv-Luc, an env-deleted and nef-inactived
HIV-1 proviral construct, and a construct expressing for
HIV envelope protein (Env) of NL4-3 (X4-tropic) as
described previously [12]. To produce HIV-1 VLPs,
HIV-1-gag-GFP/NL4-3, were generated by cotransfec-
tion of HEK293T cells with a plasmid encoding HIV-
gag-GFP and with an expression plasmid of NL4-3 Env.
Supernatants that contain HIV-1 particles were har-
vested, filtered and titrated with p24Gag capture ELISA.
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Human primary CD4+ T cells knocking down of ADAP;
C8166 cells and Jurkat cells stably overexpressing GFP
or ADAP/GFP or M12/GFP; J14, JDAP or wild type
Jurkat cells were respectively incubated with single-cycle
HIV stocks (i.e. HIV-Luc/NL4-3 containing luciferase
reporter, 1 ng or 5 ng of p24Gag) for 2 h at 37°C. After
washing of excessive HIV-1 viruses, the above cells
were incubated for further 3 days [12]. Alternatively,
anti-LFA-1 or soluble ICAM-1-Fc was used to pre-treat
T cells for 15 min and was kept in the culture medium
during the incubation time. Cells were washed inten-
sively post-infection and cell lysates were prepared to
measure luciferase activity with a kit from Promega. Or,
the amount of viruses was quantified by detecting HIV-
1-gag mRNA levels with qRT-PCR using the forward
primer (5’-GTGTGGAAAATCTCT AGCAGTGG-3’) and
the reverse primer (5’-CGCTCTCGCACCCATCTC-3’).
Actin was used as an internal reference.
HIV-1 infection and transmission between T-T cells
T cells were infected with HIV-1 strain pNL4-3 by spi-
noculation and cells were cultured for 3 days before being
used as HIV-1+ donor cells. 5 × 105 ADAP/GFP or M12/
GFP expressing target cells were mixed with 2.5 × 105
HIV + donor T cells, incubated for 0, 6, 12 and 24 hr, and
genomic DNA was extracted (Qiagen). Quantitative real-
time PCR was performed to measure HIV pol DNA and
the house-keeping gene albumin as described previously
[10,13,14] The ratio of HIV pol DNA to albumin was
determined as the HIV DNA copy number and the fold
increase was calculated relative to the amount of HIV-1
DNA at the time point 0 hr as a measure of cell-cell
spread.
Conjugate or VS formation and immunostaining
For T-T conjugation, 5 × 105 HIV+ donor cells were mixed
with an equal number of target cells at 37°C on poly-L-ly-
sine–treated coverslips for up to 1 hr as described pre-
viously [11]. Conjugates were fixed in 4% formaldehyde
and permeabilized in 0.1% Triton X-100/5% FCS. Im-
munostaining of conjugates was performed using the
following reagents: phalloidin-TRITC (Sigma-Aldrich),
anti-Env mAb (mAb 50-69, donated by S. Zoller-Pazner
and obtained from the CFAR, NIBSC, UK), rabbit antisera
against HIV-1 Gag p17 and p24 (donated by G. Reid and
obtained from the CFAR, NIBSC UK). To form DC-T
conjugation, mature DCs (2 × 105 cells) were pre-
incubated with HIV-1-p24Gag-GFP/NL4-3 VLPs (20 ng
of p24) at 37°C for 2 hr as previously described [12].
After extensive washes, these DCs were then incubated
for 30 min at a ratio of 1:1 with Jurkat cells over-
expressing ADAP/GFP or M12/GFP; J14 or JDAP;
human primary CD4+ T cells knocking down of ADAP;and the control cells respectively. Conjugates were
stained with anti-LFA-1 or anti-ADAP (BD Bioscience).
Stained coverslips were mounted in Molwiol 4-88
(Calbiochem) or Prolong Gold antifade (Invitrogen),
and analyzed using a confocal microscope linked to
LSM 510™ software (Carl Zeiss MicroImaging, Inc.) or a
Leica SP2.
Statistics analysis
Data are presented as mean±SEM. A two-tailed Stu-
dent’s t-test was used to compare two groups. ANOVA
was used to analyze difference among three groups. For
all test, a P value of 0.05 or less was considered statisti-
cally significant.
Additional files
Additional file 1: Figure S1. (A) After HIV-1 infection, Jurkat cells
overexpressing GFP, ADAP/GFP or M12/GFP expressed surface CD4 and
CXCR4 at the same levels. (B) C8166 T cells were stably transduced with GFP,
ADAP/GFP or M12/GFP. The transduced efficiency reached over 95%
according to the percent of GFP + cells by flow cytometry (left panel), and
the expression levels of ADAP or M12 were assessed by immunoblotting
(middle panel). These cells were infected with low or high doses (equivalent
to 1.5 or 15 ng p24Gag, respectively) of HIV-1, and supernatants were
collected at various times post infection to check the presence of p24Gag by
ELISA (right panel). Two independent experiments were performed and the
representative data were collected from triplicate samples with error bars. (C)
ADAP or M12 expression in C8166 cells did not affect the surface expression
levels of CD4, CXCR4, CD3, CD28, β1 integrin or ICAM-1 as determined by
flow cytometry. (D) Overexpression of ADAP or M12 in C8166 cells did not
significantly alter cell proliferative capacity. (E) Knockdown of ADAP in human
primary CD4+ T cells did not alter the surface expression levels of CD4,
CXCR4, CD3, CD28, β1 or β2 integrins and ICAM-1.
Additional file 2: Figure S2. The reporter plasmid pLTR-gag3-flag-luc
contains the HIV-1 5’ LTR promoter region, three amino acids of Gag, the
Flag tag, followed by the firefly luciferase open reading frame. (A) ADAP was
cotransfected into Jurkat cells with the report plasmids expressing wild type
HIV-1 LTR or the mutant LTR which lost NFB binding sites. The cells were
then stimulated with anti-CD3/CD28 for 6 hrs to measure the luciferase
readings. (B) Src kinase and PLCγ, but not PI3K, is essential for anti-CD3/
CD28-induced HIV-1 transcription. Jurkat cells expressing GFP or ADAP/GFP
were treated with specific inhibitors or anti-CD18, followed by a
measurement of HIV-1 LTR transcription. Three independent experiments
were performed and the representative data were collected from triplicate
samples with error bars (* represents p = <0.05, ** represents p = <0.001).
Additional file 3: Figure S3. (A) The surface expression levels of β2
integrin (i.e. CD18) on Jurkat and J14 cells were determined by flow
cytometry. (B) Jurkat and JDAP cells were stimulated with plate-coated
anti-CD3 and ICAM-1 (P = 0.0001). F-actin was stained with Phalloidin-
TRITC to observe cell spreading.
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